Depression, antidepressants, and body weight change

Area of Science:

• Pharmacology
• Metabolic Science
• Psychiatry

Background:

• Antidepressant treatment for depression is associated with significant weight gain in some patients.
• This weight gain is often problematic and appears independent of clinical improvement or episode-related weight changes.
• Altered resting metabolic rate is a potential contributing factor to antidepressant-induced weight gain.

Purpose of the Study:

• To investigate the relationship between antidepressant medications and metabolic rate.
• To explore the differential effects of various antidepressant classes on energy expenditure and weight.
• To understand the mechanisms underlying antidepressant-induced weight changes and their clinical implications.

Main Methods:

• Analysis of resting metabolic rate changes in patients treated with different antidepressant medications.
• Comparison of weight changes and metabolic effects between tricyclic antidepressants and monocyclic antidepressants (e.g., fluvoxamine).
• Assessment of appetite and food craving patterns during antidepressant treatment and depressive episodes.

Main Results:

• Tricyclic antidepressants were associated with reduced resting metabolic rate and increased energy efficiency (16-24%), potentially causing weight gain.
• Fluvoxamine, a monocyclic antidepressant, increased metabolic rate and led to weight loss.
• No significant effect of antidepressants on appetite or specific food cravings (e.g., carbohydrate craving) was observed during treatment.

Conclusions:

• Metabolic rate alterations, not appetite changes, are key mechanisms for antidepressant-induced weight gain or loss.
• Medications like fluvoxamine that increase metabolic rate may improve patient adherence by avoiding weight gain.
• Understanding these metabolic effects is crucial for optimizing antidepressant therapy and patient outcomes.